Home » Newsletters » BioWorld Science

BioWorld Science

May 22, 2003

View Archived Issues

Preclinical and clinical data on natalizumab presented at DDW 2003

Fondaparinux better than enoxaparin in preventing postsurgical venous thromboembolism

Thalidomide delays sepsis in an experimental model

Antifungal effects of N-chlorotaurine described in Glasgow

Effects of gamma-linolenic acid and arachidonic acid on the efficacy of antimicrobials

Pleconaril is well tolerated and reduces morbidity associated with picornavirus infection

CDP-571 safe, effective in patients with Crohn's disease

Mutational studies and postantibiotic effect of DK-507k and other fluoroquinolones

Enanta reports new aspartyl protease inhibitors with utility in HIV infection

ExonHit Therapeutics claims novel antitumor compounds in recent patent

Immune-selective proteasome inhibitors under study at Kyorin and Nisshin Pharma

Water-soluble etoposide prodrugs prepared and tested by French research team

CNRS researchers design novel antimalarial artemisinin derivatives

Sankyo describes new compounds with PPARgamma-agonist and antitumor activity

New 5-HT2B receptor antagonists for pain and other uses described in Biofrontera patent

Novel modulators of cellular calcium influx and their use reported by Ono

Kirin identifies new antitumor FGFR inhibitors

Chiron makes offer for PowderJect

Bextra approved in Europe

FDA review date set for Crestor

King and Elan restructure primary care acquisition agreement

TroVax trial in renal cancer cleared to begin

Remicade approved in E.U. for maintenance therapy in Crohn's disease

First anti-TNF agent approved for ankylosing spondylitis in E.U.

Millennium ships Velcade within a week of FDA approval

Intravitreal Posurdex safe and effective in persistent macular edema

New data on gabapentin combined with valaciclovir in postherpetic neuralgia

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...